Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Cancers|November 12, 2013
Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future PerspectivesMarc Dufour, Anne Dormond-Meuwly, Nicolas Demartines, et al.Biochemical and Biophysical Research Communications|August 17, 2014
PGE2-induced colon cancer growth is mediated by mTORC1Marc Dufour, Seraina Faes, Anne Dormond-Meuwly, et al.Human Immunology|August 7, 2012
Targeting the intragraft microenvironment and the development of chronic allograft rejectionOlivier Dormond, Marc Dufour, Tatsuichiro Seto, et al.Biochemical and Biophysical Research Communications|July 23, 2013
Reactivation of AKT signaling following treatment of cancer cells with PI3K inhibitors attenuates their antitumor effectsMarc Dufour, Anne Dormond-Meuwly, Catherine Pythoud, et al.Physics in Medicine and Biology|June 19, 2008
Deformable and durable phantoms with controlled density of scatterersCharles-Etienne Bisaillon, Guy Lamouche, Romain Maciejko, et al.Biochemical and Biophysical Research Communications|March 29, 2011
The inhibition of MAPK potentiates the anti-angiogenic efficacy of mTOR inhibitorsAnne Dormond-Meuwly, Didier Roulin, Marc Dufour, et al.Molecular Cancer|July 28, 2011
Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K/mTOR inhibitor, in combination with sorafenibDidier Roulin, Laurent Waselle, Anne Dormond-Meuwly, et al.BMC Cancer|March 10, 2012
Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cellsBenjamin Blaser, Laurent Waselle, Anne Dormond-Meuwly, et al.Journal of Biomedical Optics|August 31, 2010
Intravascular optical coherence tomography on a beating heart modelGuy Lamouche, Marc Dufour, Mark Hewko, et al.Cardiology in the Young|December 23, 2015
Usefulness of maximal oxygen pulse in timing of pulmonary valve replacement in patients with isolated pulmonary regurgitationAntoine Legendre, Ruddy Richard, Florence Pontnau, et al.Pageof 2